Search research articles
Contact Us
Filters
Showing results (51-60 of 210) with videos related to
Page
of 21
Sort By:
Current Molecular Pharmacology
|
January 11, 2013
Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS metastases: the Road less Travelled
Irina Veytsman, Jeanny B Aragon-Ching, Sandra M Swain
The American Journal of Managed Care
|
September 27, 2012
Treatment and cost implications of pertuzumab
Michael E Chernew, Lee N Newcomer, Sandra M Swain
Journal of the National Cancer Institute. Monographs
|
October 20, 2010
The impact of systemic therapy following ductal carcinoma in situ
Jennifer Eng-Wong, Joseph P Costantino, Sandra M Swain
Clinical Breast Cancer
|
February 3, 2004
Rationale and clinical trial design for evaluating gemcitabine as neoadjuvant and adjuvant therapy for breast cancer
Eleftherios P Mamounas, Charles E Geyer, Sandra M Swain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2015
Reply to a. Avan et Al
José Baselga, Emma Clark, Astrid Kiermaier, et al.
Expert Opinion on Emerging Drugs
|
August 31, 2006
Emerging drugs to replace current leaders in first-line therapy for breast cancer
Michael C Cox, Tu D Dan, Sandra M Swain
The New England Journal of Medicine
|
September 27, 2002
Oophorectomy in carriers of BRCA mutations
Sen H Zhuang, Gregory D Leonard, Sandra M Swain
International Journal of Oncology
|
March 15, 2011
p53, HER2 and tumor cell apoptosis correlate with clinical outcome after neoadjuvant bevacizumab plus chemotherapy in breast cancer
Sherry X Yang, Seth M Steinberg, Dat Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 9, 2008
Locally advanced and inflammatory breast cancer
Stephen Chia, Sandra M Swain, David R Byrd, et al.
Breast Cancer Research and Treatment
|
September 14, 2017
Take care of your neighborhood
Elmer E Huerta, Patricia Weeks-Coulthurst, Courtney Williams, et al.
Page
of 21
Search research articles
Search
Showing results (51-60 of 210) with videos related to
Sort By:
Page
of 21
Current Molecular Pharmacology
|
January 11, 2013
Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS metastases: the Road less Travelled
Irina Veytsman, Jeanny B Aragon-Ching, Sandra M Swain
The American Journal of Managed Care
|
September 27, 2012
Treatment and cost implications of pertuzumab
Michael E Chernew, Lee N Newcomer, Sandra M Swain
Journal of the National Cancer Institute. Monographs
|
October 20, 2010
The impact of systemic therapy following ductal carcinoma in situ
Jennifer Eng-Wong, Joseph P Costantino, Sandra M Swain
Clinical Breast Cancer
|
February 3, 2004
Rationale and clinical trial design for evaluating gemcitabine as neoadjuvant and adjuvant therapy for breast cancer
Eleftherios P Mamounas, Charles E Geyer, Sandra M Swain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2015
Reply to a. Avan et Al
José Baselga, Emma Clark, Astrid Kiermaier, et al.
Expert Opinion on Emerging Drugs
|
August 31, 2006
Emerging drugs to replace current leaders in first-line therapy for breast cancer
Michael C Cox, Tu D Dan, Sandra M Swain
The New England Journal of Medicine
|
September 27, 2002
Oophorectomy in carriers of BRCA mutations
Sen H Zhuang, Gregory D Leonard, Sandra M Swain
International Journal of Oncology
|
March 15, 2011
p53, HER2 and tumor cell apoptosis correlate with clinical outcome after neoadjuvant bevacizumab plus chemotherapy in breast cancer
Sherry X Yang, Seth M Steinberg, Dat Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 9, 2008
Locally advanced and inflammatory breast cancer
Stephen Chia, Sandra M Swain, David R Byrd, et al.
Breast Cancer Research and Treatment
|
September 14, 2017
Take care of your neighborhood
Elmer E Huerta, Patricia Weeks-Coulthurst, Courtney Williams, et al.
Page
of 21